Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

Ayman Al‐Hendy, Andrea S. Lukes, Alfred N. Poindexter, Roberta Venturella, Claudio Villarroel, Hilary Critchley, Yulan Li, Laura McKain, Juan Camilo Arjona Ferreira, Andria Langenberg,

New England Journal of Medicine · 2021 · 185 citations · 25 references

DOIFull text

Open access

Abstract

Once-daily relugolix combination therapy resulted in a significant reduction in menstrual bleeding, as compared with placebo, and preserved bone mineral density in women with uterine fibroids. (Funded by Myovant Sciences; LIBERTY 1 [L1] and LIBERTY 2 [L2] ClinicalTrials.gov numbers, NCT03049735 and NCT03103087, respectively.).

References

25